{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:59:09Z","timestamp":1776898749509,"version":"3.51.2"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":3478,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1194\/jlr.m011791","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T03:34:20Z","timestamp":1298518460000},"page":"885-896","source":"Crossref","is-referenced-by-count":43,"title":["Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice"],"prefix":"10.1016","volume":"52","author":[{"given":"Adam E.","family":"Mullick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wuxia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Witchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles P.","family":"Whipple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanne M.","family":"Crooke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M011791_bib1","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.CIR.80.4.1070","article-title":"The cholesterol controversy is over. Why did it take so long?","volume":"80","author":"Steinberg","year":"1989","journal-title":"Circulation."},{"key":"10.1194\/jlr.M011791_bib2","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1161\/01.CIR.0000143041.58692.CC","article-title":"Genetic basis of atherosclerosis: part I: new genes and pathways","volume":"110","author":"Lusis","year":"2004","journal-title":"Circulation."},{"key":"10.1194\/jlr.M011791_bib3","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications","volume":"116","author":"Tabas","year":"2007","journal-title":"Circulation."},{"key":"10.1194\/jlr.M011791_bib4","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1001\/jama.1990.03450230083034","article-title":"Lipoproteins and atherogenesis. Current concepts","volume":"264","author":"Steinberg","year":"1990","journal-title":"JAMA."},{"key":"10.1194\/jlr.M011791_bib5","first-page":"e149","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"24","author":"Grundy","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M011791_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2796.2005.01556.x","article-title":"Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis","volume":"258","author":"Olofsson","year":"2005","journal-title":"J. Intern. Med."},{"key":"10.1194\/jlr.M011791_bib7","first-page":"461","article-title":"Drug evaluation: ISIS-301012, an antisense oligonucleotide for the treatment of hypercholesterolemia","volume":"8","author":"Burnett","year":"2006","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1194\/jlr.M011791_bib8","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1345\/aph.1K065","article-title":"ISIS 301012 gene therapy for hypercholesterolemia: sense, antisense, or nonsense?","volume":"41","author":"Ito","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"10.1194\/jlr.M011791_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2796.2008.01995.x","article-title":"Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies","volume":"264","author":"Fredrikson","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1194\/jlr.M011791_bib10","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2007.08.039","article-title":"Regression of atherosclerosis with therapeutic antibodies pipe cleaner or pipe dream?","volume":"50","author":"Ginsburg","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.M011791_bib11","series-title":"Antisense Drug Technology: Principles, Strategies, and Applications","author":"Crooke","year":"2008"},{"key":"10.1194\/jlr.M011791_bib12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.108.786822","article-title":"Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice","volume":"118","author":"Merki","year":"2008","journal-title":"Circulation."},{"key":"10.1194\/jlr.M011791_bib13","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/CIRCULATIONAHA.105.606442","article-title":"Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B","volume":"114","author":"Kastelein","year":"2006","journal-title":"Circulation."},{"key":"10.1194\/jlr.M011791_bib14","first-page":"1199","article-title":"Suppression of apolipoprotein B by antisense oligonucleotides produces concomitant downstream reductions in lipogenic genes in mice and nonhuman primates","volume":"97","author":"Graham","year":"2005","journal-title":"Circulation (Scientific Sessions Abstract)."},{"key":"10.1194\/jlr.M011791_bib15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1194\/jlr.M400492-JLR200","article-title":"An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis","volume":"46","author":"Crooke","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M011791_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ecl.2008.11.011","article-title":"Other therapies for reducing low-density lipoprotein cholesterol: medications in development","volume":"38","author":"Stein","year":"2009","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1194\/jlr.M011791_bib17","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(10)60284-X","article-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial","volume":"375","author":"Raal","year":"2010","journal-title":"Lancet."},{"key":"10.1194\/jlr.M011791_bib18","doi-asserted-by":"crossref","first-page":"11994","DOI":"10.1074\/jbc.272.18.11994","article-title":"2\u2019-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells","volume":"272","author":"Baker","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M011791_bib19","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1172\/JCI25482","article-title":"Modulation of atherosclerosis in mice by Toll-like receptor 2","volume":"115","author":"Mullick","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M011791_bib20","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1194\/jlr.M500232-JLR200","article-title":"Intestinal cholesterol absorption is substantially reduced in mice deficient in both ABCA1 and ACAT2","volume":"46","author":"Temel","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M011791_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0009-9120(93)90015-X","article-title":"Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts","volume":"26","author":"Carr","year":"1993","journal-title":"Clin. Biochem."},{"key":"10.1194\/jlr.M011791_bib22","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.ATV.0000258790.35810.02","article-title":"A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome","volume":"27","author":"Hartvigsen","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M011791_bib23","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M011791_bib24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-2275(20)31171-8","article-title":"Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene","volume":"42","author":"Duchateau","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M011791_bib25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0022-2275(20)30180-2","article-title":"BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis","volume":"43","author":"Edwards","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M011791_bib26","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/hq1201.100260","article-title":"Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice","volume":"21","author":"Davis","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M011791_bib27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1194\/jlr.M400475-JLR200","article-title":"Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption","volume":"46","author":"Repa","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M011791_bib28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/CIRCRESAHA.107.149666","article-title":"Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase","volume":"101","author":"Gustafsson","year":"2007","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.M011791_bib29","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1161\/01.ATV.0000147163.54024.70","article-title":"Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis","volume":"24","author":"Khalil","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M011791_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2007.12.012","article-title":"Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases","volume":"390","author":"Nakano","year":"2008","journal-title":"Clin. Chim. Acta."},{"key":"10.1194\/jlr.M011791_bib31","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1074\/jbc.M210062200","article-title":"Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression","volume":"278","author":"Yu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M011791_bib32","doi-asserted-by":"crossref","first-page":"34268","DOI":"10.1074\/jbc.M300043200","article-title":"Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass","volume":"278","author":"Gavrilova","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M011791_bib33","doi-asserted-by":"crossref","first-page":"37603","DOI":"10.1074\/jbc.M604709200","article-title":"Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis","volume":"281","author":"Zhang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M011791_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M011791_bib35","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1210\/en.2003-0982","article-title":"Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status","volume":"144","author":"Hardie","year":"2003","journal-title":"Endocrinology."},{"key":"10.1194\/jlr.M011791_bib36","doi-asserted-by":"crossref","first-page":"21429","DOI":"10.1074\/jbc.M300287200","article-title":"Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene","volume":"278","author":"Martin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M011791_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2006.02.030","article-title":"A systematic review of LDL apheresis in the treatment of cardiovascular disease","volume":"189","author":"Thompsen","year":"2006","journal-title":"Atherosclerosis."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520408752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520408752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M011791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T21:59:03Z","timestamp":1637445543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520408752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0022227520408752"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m011791","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}